{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:58:47Z","timestamp":1792198727025,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1053\/j.ajkd.2004.12.005","type":"journal-article","created":{"date-parts":[[2005,12,13]],"date-time":"2005-12-13T11:08:01Z","timestamp":1134472081000},"page":"531-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":275,"title":["Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population"],"prefix":"10.1053","volume":"45","author":[{"given":"Consuelo","family":"Huerta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Castellsague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Varas-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alberto","family":"Garc\u00eda Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2004.12.005_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJM199802123380707","article-title":"Analgesic nephropathy","volume":"338","author":"De Broe","year":"1998","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2004.12.005_bib2","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0272-6386(96)90570-3","article-title":"The renal effects of nonsteroidal anti-inflammatory drugs","volume":"28","author":"Bennett","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2004.12.005_bib3","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/rheumatology\/XXXIV.suppl_1.25","article-title":"Non-steroidal anti-inflammatory drugs and renal function","volume":"34","author":"Delmas","year":"1995","journal-title":"Br J Rheumatol"},{"issue":"suppl 6","key":"10.1053\/j.ajkd.2004.12.005_bib4","first-page":"S17","article-title":"Non-steroidal anti-inflammatory drugs and the continuum of renal dysfunction","volume":"20","author":"Epstein","year":"2002","journal-title":"J Hypertens"},{"key":"10.1053\/j.ajkd.2004.12.005_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2796.2003.01146.x","article-title":"Adverse renal effects of anti-inflammatory agents","volume":"253","author":"Gambaro","year":"2003","journal-title":"J Intern Med"},{"key":"10.1053\/j.ajkd.2004.12.005_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.pa.33.040193.002251","article-title":"Renal toxicity of the nonsteroidal anti-inflammatory drugs","volume":"33","author":"Murray","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1053\/j.ajkd.2004.12.005_bib7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/jama.1996.03540060042033","article-title":"Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs","volume":"276","author":"Radford","year":"1996","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2004.12.005_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0272-6386(89)80130-1","article-title":"Minimal change glomerulopathy associated with nonsteroidal anti-inflammatory drugs","volume":"13","author":"Warren","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2004.12.005_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/j.1552-4604.1988.tb05755.x","article-title":"Drug-induced parenchymal renal disease in outpatients","volume":"28","author":"Beard","year":"1988","journal-title":"J Clin Pharmacol"},{"key":"10.1053\/j.ajkd.2004.12.005_bib10","series-title":"Side-Effects of Anti-Inflammatory Drugs, Part 2","first-page":"367","article-title":"Hospitalizations for renal impairment among users and non-users of non-steroidal anti-inflammatory drugs in Saskatchewan, Canada, 1983","author":"Guess","year":"1985"},{"key":"10.1053\/j.ajkd.2004.12.005_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.2630010103","article-title":"Non-steroidal anti-inflammatory drugs and acute renal disease","volume":"1","author":"Beard","year":"1992","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1053\/j.ajkd.2004.12.005_bib12","first-page":"551","article-title":"Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure","volume":"88","author":"Evans","year":"1995","journal-title":"Q J Med"},{"key":"10.1053\/j.ajkd.2004.12.005_bib13","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.1996.00440200041005","article-title":"Non-steroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure","volume":"156","author":"P\u00e9rez Gutthann","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2004.12.005_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2125.1997.00631.x","article-title":"Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects","volume":"44","author":"Henry","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.ajkd.2004.12.005_bib15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/oxfordjournals.aje.a010234","article-title":"Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons","volume":"151","author":"Griffin","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.ajkd.2004.12.005_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2125.1998.00701.x","article-title":"Use of the UK General Practice Research Database for pharmacoepidemiology","volume":"45","author":"Garc\u00eda Rodr\u00edguez","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.ajkd.2004.12.005_bib17","series-title":"Pharmacoepidemiology","first-page":"375","article-title":"The UK General Practice Research Database","author":"Garc\u00eda Rodr\u00edguez","year":"2000"},{"key":"10.1053\/j.ajkd.2004.12.005_bib18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/bmj.302.6779.766","article-title":"Validation of information recorded on general practitioner based computerised data resource in the United Kingdom","volume":"302","author":"Jick","year":"1991","journal-title":"BMJ"},{"key":"10.1053\/j.ajkd.2004.12.005_bib19","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1592\/phco.19.10.854.31550","article-title":"Low-dose diclofenac, naproxen, and ibuprofen cohort study","volume":"19","author":"P\u00e9rez Gutthann","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.ajkd.2004.12.005_bib20","first-page":"157","article-title":"Les insuffisances r\u00e9nales d\u2019origine m\u00e9dicamenteuse","volume":"10","author":"Vigeral","year":"1989","journal-title":"Nephrologie"},{"key":"10.1053\/j.ajkd.2004.12.005_bib21","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","author":"Hardman","year":"1996"},{"key":"10.1053\/j.ajkd.2004.12.005_bib22","series-title":"Modern Epidemiology","author":"Rothman","year":"1986"},{"key":"10.1053\/j.ajkd.2004.12.005_bib23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00001648-199209000-00012","article-title":"Confidence interval estimation of interaction","volume":"3","author":"Hosmer","year":"1992","journal-title":"Epidemiology"},{"key":"10.1053\/j.ajkd.2004.12.005_bib24","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1136\/heart.85.4.e8","article-title":"Serious adverse events experienced by patients with chronic heart failure taking spironolactone","volume":"85","author":"Berry","year":"2001","journal-title":"Heart"},{"key":"10.1053\/j.ajkd.2004.12.005_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/oxfordjournals.ndt.a092076","article-title":"Acute renal failure after the use of angiotensin-converting-enzyme inhibitors in patients without renal artery stenosis","volume":"7","author":"Bridoux","year":"1992","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2004.12.005_bib26","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0272-6386(96)90570-3","article-title":"The renal effects of nonsteroidal anti-inflammatory drugs","volume":"28","author":"Bennet","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"suppl","key":"10.1053\/j.ajkd.2004.12.005_bib27","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/S0002-9343(99)00113-8","article-title":"Nephrotoxicity of nonsteroidal anti-inflammatory drugs","volume":"106","author":"Whelton","year":"1999","journal-title":"Am J Med"},{"key":"10.1053\/j.ajkd.2004.12.005_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"2004","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1053\/j.ajkd.2004.12.005_bib29","first-page":"S37","article-title":"Using prescription claims for drugs available over-the-counter (OTC)","volume":"9","author":"Ulcickas","year":"2000","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1053\/j.ajkd.2004.12.005_bib30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/pds.736","article-title":"The safety of drugs for OTC use","volume":"11","author":"MacDonald","year":"2002","journal-title":"Pharmacoepidemiol Drug Safety"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638604016191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638604016191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:29:29Z","timestamp":1759454969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638604016191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0272638604016191"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2004.12.005","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2004.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}